The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration
Open accessAbstract
Neuroinflammatory response is primarily a protective mechanism in the brain. However, excessive and chronic inflammatory responses can lead to deleterious effects involving immune cells, brain cells and signaling molecules. Neuroinflammation induces and accelerates pathogenesis of Parkinson's disease (PD), Alzheimer's disease (AD) and Multiple sclerosis (MS). Neuroinflammatory pathways are indicated as novel therapeutic targets for these diseases. Mast cells are immune cells of hematopoietic origin that regulate inflammation and upon activation release many proinflammatory mediators in systemic and central nervous system (CNS) inflammatory conditions. In addition, inflammatory mediators released from activated glial cells induce neurodegeneration in the brain. Systemic inflammation-derived proinflammatory cytokines/chemokines and other factors cause a breach in the blood brain-barrier (BBB) thereby allowing for the entry of immune/inflammatory cells including mast cell progenitors, mast cells and proinflammatory cytokines and chemokines into the brain. These peripheral-derived factors and intrinsically generated cytokines/chemokines, α-synuclein, corticotropin-releasing hormone (CRH), substance P (SP), beta amyloid 1-42 (Aβ1-42) peptide and amyloid precursor proteins can activate glial cells, T-cells and mast cells in the brain can induce additional release of inflammatory and neurotoxic molecules contributing to chronic neuroinflammation and neuronal death. The glia maturation factor (GMF), a proinflammatory protein discovered in our laboratory released from glia, activates mast cells to release inflammatory cytokines and chemokines. Chronic increase in the proinflammatory mediators induces neurotoxic Aβ and plaque formation in AD brains and neurodegeneration in PD brains. Glial cells, mast cells and T-cells can reactivate each other in neuroinflammatory conditions in the brain and augment neuroinflammation. Further, inflammatory mediators from the brain can also enter into the peripheral system through defective BBB, recruit immune cells into the brain, and exacerbate neuroinflammation. We suggest that mast cell-associated inflammatory mediators from systemic inflammation and brain could augment neuroinflammation and neurodegeneration in the brain. This review article addresses the role of some atypical inflammatory mediators that are associated with mast cell inflammation and their activation of glial cells to induce neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J., Knapp, D. J., & Crews, F. T. (2007) · Glia · doi:10.1002/glia.20467 · Cited by 2,144 · cited 1×
“…injection of TNF-α into an adult mouse activates brain microglia to produce proinflammatory mediators that induces death of dopaminergic neurons in the substantia nigra (Qin et al., 2007), and this demonstrates a direct link between systemic inflammatory factors and neurodegeneration in the brain.”
BackgroundMicroglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485
The role of inflammation in CNS injury and disease
Lucas, S., Rothwell, N. J., & Gibson, R. M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706400 · Cited by 1,272
Tracey, K. J. (2009) · Nature Reviews Immunology · doi:10.1038/nri2566 · Cited by 1,154 · cited 1×
“Peripheral inflammation is also translated to the brain through the vagus nerve by neural reflex (Tracey, 2009).”
BackgroundSystemic inflammation and disease progression in Alzheimer disease
Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., & Perry, V. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b6bb95 · Cited by 1,139 · cited 1×
“Increased TNF-α levels due to either acute or chronic systemic inflammation have been shown to increase cognitive decline in AD (Holmes et al., 2009) and neurodegeneration in PD (Litteljohn et al., 2010).”
BackgroundCytokines and acute neurodegeneration
Allan, S. M., & Rothwell, N. J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35094583 · Cited by 1,123
Three or more routes for leukocyte migration into the central nervous system
Ransohoff, R. M., Kivisäkk, P., & Kidd, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1130 · Cited by 1,052
Innate immunity in the central nervous system
Ransohoff, R. M., & Brown, M. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58644 · Cited by 1,034 · cited 1×
“The brain was originally considered as an immunologically privileged organ but now it is well known that the peripheral immune system and the brain communicate through several pathways (Ransohoff and Brown, 2012).”
BackgroundSystemic infections and inflammation affect chronic neurodegeneration
Perry, V. H., Cunningham, C., & Holmes, C. (2007) · Nature Reviews Immunology · doi:10.1038/nri2015 · Cited by 1,027
Interleukin-1 and neuronal injury
Allan, S. M., Tyrrell, P. J., & Rothwell, N. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1664 · Cited by 992
Systemic inflammation and microglial activation: systematic review of animal experiments
Hoogland, I. C. M., Houbolt, C., van Westerloo, D. J., van Gool, W. A., & van de Beek, D. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0332-6 · Cited by 957
Role of neuroinflammation in neurodegenerative diseases (Review)
CHEN, W.-W., ZHANG, X., & HUANG, W.-J. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4948 · Cited by 932
The movers and shapers in immune privilege of the CNS
Engelhardt, B., Vajkoczy, P., & Weller, R. O. (2017) · Nature Immunology · doi:10.1038/ni.3666 · Cited by 893 · cited 2×
“The existence of bidirectional communication between the brain and the peripheral immune system has been known over the past two decades (Johnson et al., 1997; Dantzer et al., 2000; Holmes and Butchart, 2011; Hernández-Romero et al., 2012; McCusker and Kelley, 2013; Träger and Tabrizi, 2013; Engelhardt et al., 2017).”
BackgroundLee, H.-J., Suk, J.-E., Patrick, C., Bae, E.-J., Cho, J.-H., Rho, S., Hwang, D., Masliah, E., & Lee, S.-J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081125 · Cited by 877
Neuroinflammation Induces Neurodegeneration.
Kempuraj, D., Thangavel, R., Natteru, P., Selvakumar, G. P., Saeed, D., Zahoor, H., Zaheer, S., Iyer, S. S., & Zaheer, A. (2016) · PubMed · Cited by 872
Self-citationInflammatory Mediators and Modulation of Blood–Brain Barrier Permeability
Abbott, N. J. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007074420772 · Cited by 803
Blum-Degena, D., Müller, T., Kuhn, W., Gerlach, M., Przuntek, H., & Riederer, P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12192-7 · Cited by 801
Passage of cytokines across the blood–brain barrier
Banks, W. A., Kastin, A. J., & Broadwell, R. D. (1996) · Neuroimmunomodulation · doi:10.1159/000097202 · Cited by 778
A role for uncoupling protein‐2 as a regulator of mitochondrial hydrogen peroxide generation
Nègre‐Salvayre, A., Hirtz, C., Carrera, G., Cazenave, R., Troly, M., Salvayre, R., Pénicaud, L., & Casteilla, L. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.10.9271366 · Cited by 760
New developments in mast cell biology
Kalesnikoff, J., & Galli, S. J. (2008) · Nature Immunology · doi:10.1038/ni.f.216 · Cited by 748
Immunomodulatory mast cells: negative, as well as positive, regulators of immunity
Galli, S. J., Grimbaldeston, M., & Tsai, M. (2008) · Nature Reviews Immunology · doi:10.1038/nri2327 · Cited by 738
Blood–brain barrier dysfunction in parkinsonian midbrain in vivo
Kortekaas, R., Leenders, K. L., van Oostrom, J. C. H., Vaalburg, W., Bart, J., Willemsen, A. T. M., & Hendrikse, N. H. (2005) · Annals of Neurology · doi:10.1002/ana.20369 · Cited by 733
Cytokine networks in neuroinflammation
Becher, B., Spath, S., & Goverman, J. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.123 · Cited by 697
Theoharides, T. C., Alysandratos, K.-D., Angelidou, A., Delivanis, D.-A., Sismanopoulos, N., Zhang, B., Asadi, S., Vasiadi, M., Weng, Z., Miniati, A., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.014 · Cited by 680
Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease
Shi, M., Liu, C., Cook, T. J., Bullock, K. M., Zhao, Y., Ginghina, C., Li, Y., Aro, P., Dator, R., He, C., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1314-y · Cited by 676
The role of peripheral immune cells in the CNS in steady state and disease
Prinz, M., & Priller, J. (2017) · Nature Neuroscience · doi:10.1038/nn.4475 · Cited by 657
Cunningham, C., Campion, S., Lunnon, K., Murray, C. L., Woods, J. F. C., Deacon, R. M. J., Rawlins, J. N. P., & Perry, V. H. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.07.024 · Cited by 584 · cited 2×
“cognitive changes and accelerate neurodegenerative disease pathogenesis (Perry, 2004; Perry et al., 2007; Cunningham et al., 2009).”
BackgroundPerry, V. H. (2004) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2004.01.004 · Cited by 560
Nobili, A., Latagliata, E. C., Viscomi, M. T., Cavallucci, V., Cutuli, D., Giacovazzo, G., Krashia, P., Rizzo, F. R., Marino, R., Federici, M., et al. (2017) · Nature Communications · doi:10.1038/ncomms14727 · Cited by 514 · cited 1×
“DOPAMINE IN NEUROINFLAMMATION Neurotransmitter dopamine is implicated in the pathogenesis of PD and in AD (Bisaglia et al., 2014; Nobili et al., 2017).”
BackgroundProtective and toxic roles of dopamine in Parkinson's disease
Segura‐Aguilar, J., Paris, I., Muñoz, P., Ferrari, E., Zecca, L., & Zucca, F. A. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12686 · Cited by 498
NLRP3 inflammasome in neurological diseases, from functions to therapies
Song, L., Pei, L., Yao, S., Wu, Y., & Shang, Y. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00063 · Cited by 467
Zhou, Y., Lu, M., Du, R.-H., Qiao, C., Jiang, C.-Y., Zhang, K.-Z., Ding, J.-H., & Hu, G. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0094-3 · Cited by 455
Neuropeptides activate human mast cell degranulation and chemokine production
Kulka, M., Sheen, C. H., Tancowny, B. P., Grammer, L. C., & Schleimer, R. P. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02705.x · Cited by 445
Expression of CXCR4 and CXCL12 (SDF‐1) in human prostate cancers (PCa) in vivo
Sun, Y., Wang, J., Shelburne, C. E., Lopatin, D. E., Chinnaiyan, A. M., Rubin, M. A., Pienta, K. J., & Taichman, R. S. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10522 · Cited by 443
Mast Cells Are Essential for Early Onset and Severe Disease in a Murine Model of Multiple Sclerosis
Secor, V. H., Secor, W. E., Gutekunst, C.-A., & Brown, M. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.813 · Cited by 430
Immune–neural connections: how the immune system’s response to infectious agents influences behavior
McCusker, R. H., & Kelley, K. W. (2013) · Journal of Experimental Biology · doi:10.1242/jeb.073411 · Cited by 429
Dantzer, R., Konsman, J.-P., Bluthé, R.-M., & Kelley, K. W. (2000) · Autonomic Neuroscience · doi:10.1016/s1566-0702(00)00220-4 · Cited by 400 · cited 2×
“The existence of bidirectional communication between the brain and the peripheral immune system has been known over the past two decades (Johnson et al., 1997; Dantzer et al., 2000; Holmes and Butchart, 2011; Hernández-Romero et al., 2012; McCusker and Kelley, 2013; Träger and Tabrizi, 2013; Engelhardt et al., 2017).”
BackgroundMekori, Y. A., & Metcalfe, D. D. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.917305.x · Cited by 389
Brain Pericytes As Mediators of Neuroinflammation
Rustenhoven, J., Jansson, D., Smyth, L. C., & Dragunow, M. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.12.001 · Cited by 371
Pathway across the blood–brain barrier
Ek, M., Engblom, D., Saha, S., Blomqvist, A., Jakobsson, P.-J., & Ericsson-Dahlstrand, A. (2001) · Nature · doi:10.1038/35068632 · Cited by 348
Inflammation in central nervous system injury
Allan, S. M., & Rothwell, N. J. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2003.1358 · Cited by 345
Cardoso, A. L., Guedes, J. R., Pereira de Almeida, L., & Pedroso de Lima, M. C. (2012) · Immunology · doi:10.1111/j.1365-2567.2011.03514.x · Cited by 336
Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease
Holmes, C. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.6.788 · Cited by 329
Mast cells in the promotion and limitation of chronic inflammation
Metz, M., Grimbaldeston, M. A., Nakae, S., Piliponsky, A. M., Tsai, M., & Galli, S. J. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00520.x · Cited by 302
Neuroinflammation in Neurodegenerative Disorders-a Review
Schain, M., & Kreisl, W. C. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0733-2 · Cited by 301
Mast cells as targets of corticotropin-releasing factor and related peptides
Theoharides, T. C., Donelan, J. M., Papadopoulou, N., Cao, J., Kempuraj, D., & Conti, P. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.09.007 · Cited by 300
Self-citationCao, J., Papadopoulou, N., Kempuraj, D., Boucher, W. S., Sugimoto, K., Cetrulo, C. L., & Theoharides, T. C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7665 · Cited by 285
Self-citationContribution of systemic inflammation to chronic neurodegeneration
Perry, V. H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0722-x · Cited by 277
Cellular and Molecular Mediators of Neuroinflammation in the Pathogenesis of Parkinson’s Disease
More, S. V., Kumar, H., Kim, I. S., Song, S.-Y., & Choi, D.-K. (2013) · Mediators of Inflammation · doi:10.1155/2013/952375 · Cited by 258
Targeting neuroinflammation in Alzheimer’s disease
Bronzuoli, M. R., Iacomino, A., Steardo, L., & Scuderi, C. (2016) · Journal of Inflammation Research · doi:10.2147/jir.s86958 · Cited by 255
Teeling, J. L., & Perry, V. H. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.07.031 · Cited by 252
Esposito, P., Chandler, N., Kandere, K., Basu, S., Jacobson, S., Connolly, R., Tutor, D., & Theoharides, T. C. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.038497 · Cited by 252
Mast cells, glia and neuroinflammation: partners in crime?
Skaper, S. D., Facci, L., & Giusti, P. (2014) · Immunology · doi:10.1111/imm.12170 · Cited by 250
Role of neuroinflammation in neurodegeneration: new insights
McManus, R. M., & Heneka, M. T. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0241-2 · Cited by 247
Microglia and mast cells: two tracks on the road to neuroinflammation
Skaper, S. D., Giusti, P., & Facci, L. (2012) · The FASEB Journal · doi:10.1096/fj.11-197194 · Cited by 235
IL-1 Induces Vesicular Secretion of IL-6 without Degranulation from Human Mast Cells
Kandere-Grzybowska, K., Letourneau, R., Kempuraj, D., Donelan, J., Poplawski, S., Boucher, W., Athanassiou, A., & Theoharides, T. C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.9.4830 · Cited by 233
Self-citationMast Cells Migrate from Blood to Brain
Silverman, A.-J., Sutherland, A. K., Wilhelm, M., & Silver, R. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00401.2000 · Cited by 228
Takeda, S., Sato, N., & Morishita, R. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00171 · Cited by 223
Parkinson's Disease and Systemic Inflammation
Ferrari, C. C., & Tarelli, R. (2011) · Parkinson's Disease · doi:10.4061/2011/436813 · Cited by 218
Mast Cells as Sensors of Cell Injury through IL-33 Recognition
Enoksson, M., Lyberg, K., Möller-Westerberg, C., Fallon, P. G., Nilsson, G., & Lunderius-Andersson, C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003383 · Cited by 218
Villarán, R. F., Espinosa‐Oliva, A. M., Sarmiento, M., De Pablos, R. M., Argüelles, S., Delgado‐Cortés, M. J., Sobrino, V., Van Rooijen, N., Venero, J. L., Herrera, A. J., et al. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06879.x · Cited by 214
Alpha synuclein is transported into and out of the brain by the blood-brain barrier
Sui, Y.-T., Bullock, K. M., Erickson, M. A., Zhang, J., & Banks, W. A. (2014) · Peptides · doi:10.1016/j.peptides.2014.09.018 · Cited by 212 · cited 2×
“…al., 2017). α-synuclein is produced by cells in the peripheral tissues as well as from the CNS cells; it is also reported in the blood along with CSF (Sui et al., 2014). α-synuclein is present in the neurons and glia of substantia nigra, thalamus, neocortex and hippocampus. α-synuclein is…”
BackgroundThe Diverse Roles of Mast Cells
Gurish, M. F., & Austen, K. F. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.1.f1 · Cited by 211
de Pablos, R. M., Herrera, A. J., Espinosa-Oliva, A. M., Sarmiento, M., Muñoz, M. F., Machado, A., & Venero, J. L. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-34 · Cited by 201
Andrews, Z. B., Horvath, B., Barnstable, C. J., Elseworth, J., Yang, L., Beal, M. F., Roth, R. H., Matthews, R. T., & Horvath, T. L. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4269-04.2005 · Cited by 199 · cited 1×
“UCP2 and UCP4, members of the UCP family are neuroprotective by reducing the formation of ROS and are implicated in neurodegeneration and brain injury (Normoyle et al., 2015), AD (Wu et al., 2010) and PD (Andrews et al., 2005; Ho et al., 2012; Peixoto et al., 2013).”
BackgroundSubstance P induces TNF-α and IL-6 production through NFκB in peritoneal mast cells
Azzolina, A., Bongiovanni, A., & Lampiasi, N. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.09.003 · Cited by 196
Inflammation in Parkinson's Disease
Tufekci, K. U., Meuwissen, R., Genc, S., & Genc, K. (2012) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/b978-0-12-398314-5.00004-0 · Cited by 196
Kempuraj, D., Papadopoulou, N. G., Lytinas, M., Huang, M., Kandere-Grzybowska, K., Madhappan, B., Boucher, W., Christodoulou, S., Athanassiou, A., & Theoharides, T. C. (2004) · Endocrinology · doi:10.1210/en.2003-0805 · Cited by 182
Self-citationThe CRF Family of Neuropeptides and their Receptors - Mediators of the Central Stress Response
Dedic, N., Chen, A., & Deussing, J. M. (2018) · Current Molecular Pharmacology · doi:10.2174/1874467210666170302104053 · Cited by 182
Focal brain inflammation and autism
Theoharides, T. C., Asadi, S., & Patel, A. B. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-46 · Cited by 178
Mast cells on the mind: new insights and opportunities
Silver, R., & Curley, J. P. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.06.001 · Cited by 176
Béraud, D., Hathaway, H. A., Trecki, J., Chasovskikh, S., Johnson, D. A., Johnson, J. A., Federoff, H. J., Shimoji, M., Mhyre, T. R., & Maguire-Zeiss, K. A. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9401-0 · Cited by 172
α-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease
Mullin, S., & Schapira, A. H. V. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8394-x · Cited by 166
The role of neuroinflammation on the pathogenesis of Parkinson's disease
Chung, Y. C., Ko, H. W., Bok, E., Park, E. S., Huh, S. H., Nam, J. H., & Jin, B. K. (2010) · BMB Reports · doi:10.5483/bmbrep.2010.43.4.225 · Cited by 163
Mast Cells and Neuroinflammation
Dong, H., Zhang, X., & Qian, Y. (2014) · Medical Science Monitor Basic Research · doi:10.12659/msmbr.893093 · Cited by 160
Neuroinflammation in Alzheimer's Disease
Sawikr, Y., Yarla, N. S., Peluso, I., Kamal, M. A., Aliev, G., & Bishayee, A. (2017) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2017.02.001 · Cited by 158
Inflammasomes, hormesis, and antioxidants in neuroinflammation: Role of NRLP3 in Alzheimer disease
Pennisi, M., Crupi, R., Di Paola, R., Ontario, M. L., Bella, R., Calabrese, E. J., Crea, R., Cuzzocrea, S., & Calabrese, V. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23986 · Cited by 157
Mast Cell Biology: Introduction and Overview
Gilfillan, A. M., Austin, S. J., & Metcalfe, D. D. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9533-9_1 · Cited by 155
Corticotropin-releasing hormone and the blood-brain-barrier
Theoharis, C. (2006) · Frontiers in bioscience · doi:10.2741/2174 · Cited by 152
Neuroinflammation as Fuel for Axonal Regeneration in the Injured Vertebrate Central Nervous System
Bollaerts, I., houcke, J. V., Andries, L., Groef, L. D., & Moons, L. (2017) · Mediators of Inflammation · doi:10.1155/2017/9478542 · Cited by 148
Vascular Endothelial Growth Factor (VEGF), Mast Cells and Inflammation
Shaik-Dasthagirisaheb, Y. B., Varvara, G., Murmura, G., Saggini, A., Potalivo, G., Caraffa, A., Antinolfi, P., Tetè, S., Tripodi, D., Conti, F., et al. (2013) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201302600206 · Cited by 146
Ramsden, D. B., Ho, P. W., Ho, J. W.-M., Liu, H., So, D. H. ‐., Tse, H., Chan, K., & Ho, S. (2012) · Brain and Behavior · doi:10.1002/brb3.55 · Cited by 139
Skaper, S. D., Facci, L., & Giusti, P. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8487-6 · Cited by 139
Mast cells, brain inflammation and autism
Theoharides, T. C., Stewart, J. M., Panagiotidou, S., & Melamed, I. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.086 · Cited by 138
Takeda, S., Sato, N., Ikimura, K., Nishino, H., Rakugi, H., & Morishita, R. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.02.010 · Cited by 135 · cited 6×
“Additionally, peripheral inflammation also increases brain inflammatory responses through several mechanisms (Machado et al., 2011; Hernández-Romero et al., 2012; Takeda et al., 2013).”
BackgroundInfluentialEffect of stress on brain inflammation and multiple sclerosis
Karagkouni, A., Alevizos, M., & Theoharides, T. C. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.02.006 · Cited by 135
Taracanova, A., Alevizos, M., Karagkouni, A., Weng, Z., Norwitz, E. R., Conti, P., Leeman, S. E., & Theoharides, T. C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524845114 · Cited by 134
Inflammatory Factors Contribute to Depression and Its Comorbid Conditions
Anisman, H., & Hayley, S. P. (2012) · Science Signaling · doi:10.1126/scisignal.2003579 · Cited by 133
Silver, M. R., Margulis, A. R., Wood, N. L., Goldman, S. J., Kasaian, M. T., & Chaudhary, D. (2009) · Inflammation Research · doi:10.1007/s00011-009-0088-5 · Cited by 130
Skaper, S. D., & Facci, L. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0391 · Cited by 129
Modulation of neuroinflammation: Role and therapeutic potential of TRPV1 in the neuro-immune axis
Kong, W., Peng, Y., & Peng, B. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.03.007 · Cited by 128
TANZOLA, M., Robbie‐Ryan, M., Gutekunst, C., & Brown, M. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4385 · Cited by 127
Neurotransmitters and Microglial-Mediated Neuroinflammation
Lee, M. (2013) · Current Protein and Peptide Science · doi:10.2174/1389203711314010005 · Cited by 120
Non-Steroidal Anti-Inflammatory Drugs and Alzheimers Disease: The Epidemiological Evidence
Szekely, C. A., & Zandi, P. P. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791012026 · Cited by 116
The uncoupling protein 2 modulates the cytokine balance in innate immunity☆
ROUSSET, S., EMRE, Y., JOINLAMBERT, O., HURTAUD, C., RICQUIER, D., & CASSARDDOULCIER, A. (2006) · Cytokine · doi:10.1016/j.cyto.2006.07.012 · Cited by 114
Cytokines as a stressor: implications for depressive illness
Anisman, H., Hayley, S. P., Turrin, N. P., & Merali, Z. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003097 · Cited by 110
Brown, M. A., & Hatfield, J. K. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00147 · Cited by 109
Lim, R. Y., Miller, J. F., & Zaheer, A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3901 · Cited by 109
Self-citationInflammatory Mechanisms of Neurodegeneration in Toxin-Based Models of Parkinson's Disease
Litteljohn, D., Mangano, E. N., Clarke, M., Bobyn, J., Moloney, K., & Hayley, S. P. (2010) · Parkinson s Disease · doi:10.4061/2011/713517 · Cited by 108
Mast Cell Tryptase Induces Microglia Activation via Protease-activated Receptor 2 Signaling
Zhang, S., Zeng, X., Yang, H., Hu, G., & He, S. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000171029 · Cited by 108
Neurotensin and CRH Interactions Augment Human Mast Cell Activation
Alysandratos, K., Asadi, S., Angelidou, A., Zhang, B., Sismanopoulos, N., Yang, H., Critchfield, A. S., & Theoharides, T. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048934 · Cited by 106
The role of mast cells in neuroinflammation
Nelissen, S., Lemmens, E., Geurts, N., Kramer, P. P. G., Maurer, M., Hendriks, J. J. A., & Hendrix, S. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1092-y · Cited by 102
Asadi, S., Alysandratos, K., Angelidou, A., Miniati, A., Sismanopoulos, N., Vasiadi, M., Zhang, B., Kalogeromitros, D. C., & Theoharides, T. C. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.334 · Cited by 101
Systemic inflammation and Alzheimer's disease
Holmes, C., & Butchart, J. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390898 · Cited by 101
Hernández-Romero, M. C., Delgado-Cortés, M. J., Sarmiento, M., de Pablos, R. M., Espinosa-Oliva, A. M., Argüelles, S., Bández, M. J., Villarán, R. F., Mauriño, R., Santiago, M., et al. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.01.018 · Cited by 100
Thornton, E., & Vink, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034138 · Cited by 99
Protease-Activated Receptors: Regulation of Neuronal Function
Saito, T., & Bunnett, N. W. (2005) · NeuroMolecular Medicine · doi:10.1385/nmm:7:1-2:079 · Cited by 97
A focus on mast cells and pain
Héron, A., & Dubayle, D. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.09.018 · Cited by 97
T lymphocyte subpopulations and activation markers correlate with severity of Alzheimer's disease.
Shalit, F., Sredni, B., Brodie, C., Kott, E., & Huberman, M. (1995) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1995.1078 · Cited by 97
McKenzie, J., Spielman, L. J., Pointer, C. B., Lowry, J. R., Bajwa, E., Lee, C. W., & Klegeris, A. (2017) · Current Aging Science · doi:10.2174/1874609810666170315113244 · Cited by 97
Zhang, S., Dong, H., Zhang, X., Li, N., Sun, J., & Qian, Y. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.11.003 · Cited by 96
Li, L., Sun, Q., Li, Y., Yang, Y., Yang, Y., Chang, T., Man, M., & Zheng, L. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0526-5 · Cited by 94
Zaheer, A., Zaheer, S. A., Sahu, S. K., Knight, S., Khosravi, H., Mathur, S. N., & Lim, R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04385.x · Cited by 94
Self-citationBlock, M. L., Li, G., Qin, L., Wu, X., Pei, Z., Wang, T., Wilson, B. C., Yang, J. H., & Hong, J. (2006) · The FASEB Journal · doi:10.1096/fj.05-4553com · Cited by 93
Activation of Microglia by Histamine and Substance P
Zhu, J., Qu, C., Lü, X., & Zhang, S. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000363041 · Cited by 92
Dopamine‐Angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease
Labandeira-García, J. L., Rodríguez‐Pallares, J., Dominguez‐Meijide, A., Valenzuela, R., Villar‐Cheda, B., & Rodriguez-Perez, A. I. (2013) · Movement Disorders · doi:10.1002/mds.25614 · Cited by 91
Molecular Cloning and Expression of Biologically Active Human Glia Maturation Factor‐β
Kaplan, R., Zaheer, A., Jaye, M., & Lim, R. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb03777.x · Cited by 90
Self-citationWang, Q., Chu, C., Li, Q., Chen, S., Wilson, B. C., Oyarzabal, E. A., Jiang, L., Ali, S. F., Robinson, B. L., Kim, H., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.2238-14.2014 · Cited by 89
Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?
Bisaglia, M., Filograna, R., Beltramini, M., & Bubacco, L. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2013.12.009 · Cited by 88
Central nervous system neurons acquire mast cell products via transgranulation
Wilhelm, M., Silver, R., & Silverman, A. J. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04429.x · Cited by 88
Peripheral Biomarkers of Alzheimer's Disease
Khan, T. K., & Alkon, D. L. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142262 · Cited by 87
Mast Cells in Allergic and Inflammatory Diseases
Sismanopoulos, N., Delivanis, D.-A., Alysandratos, K.-D., Angelidou, A., Therianou, A., Kalogeromitros, D., & C. Theoharides, T. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212800165997 · Cited by 87
Ho, P. W., Ho, J. W.-M., Liu, H., So, D. H. ‐., Tse, Z. H., Chan, K., Ramsden, D. B., & Ho, S. (2012) · Translational Neurodegeneration · doi:10.1186/2047-9158-1-3 · Cited by 87
Hösli, L., Hösli, E., Schneider, U., & Wiget, W. (1984) · Neuroscience Letters · doi:10.1016/0304-3940(84)90052-1 · Cited by 86
Kim, D. Y., Hong, G. U., & Ro, J. Y. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-25 · Cited by 85
Substance P spinal signaling induces glial activation and nociceptive sensitization after fracture
Li, W.-W., Guo, T.-Z., Shi, X., Sun, Y., Wei, T., Clark, D. J., & Kingery, W. S. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.09.036 · Cited by 82
Histamine from Brain Resident MAST Cells Promotes Wakefulness and Modulates Behavioral States
Chikahisa, S., Kodama, T., Soya, A., Sagawa, Y., Ishimaru, Y., Séi, H., & Nishino, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078434 · Cited by 81
Kempuraj, D., Khan, M. M., Thangavel, R., Xiong, Z., Yang, E., & Zaheer, A. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9439-7 · Cited by 81
Self-citationSayed, B. A., Walker, M. E., & Brown, M. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003574 · Cited by 79
Culley, D. J., Snayd, M., Baxter, M. G., Xie, Z., Lee, I. H., Rudolph, J. L., Inouye, S. K., Marcantonio, E. R., & Crosby, G. J. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00107 · Cited by 78
The mitochondrial uncoupling protein‐2 is a master regulator of both M1 and M2 microglial responses
Simone, R. D., Ajmone‐Cat, M. A., Pandolfi, M., Bernardo, A., Nuccio, C. D., Minghetti, L., & Visentin, S. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13244 · Cited by 75
He, Q., Wang, Q., Yuan, C., & Wang, Y. (2017) · Glia · doi:10.1002/glia.23153 · Cited by 75
Zaheer, A., Yorek, M. A., & Lim, R. (2001) · Neurochemical Research · doi:10.1023/a:1014241300179 · Cited by 73
Self-citationZaheer, A., Zaheer, S. A., Thangavel, R., Wu, Y., Sahu, S. K., & Yang, B. (2008) · Brain Research · doi:10.1016/j.brainres.2008.02.093 · Cited by 73
Self-citationIkeda, K., Kundu, R. K., Ikeda, S., Kobara, M., Matsubara, H., & Quertermous, T. (2006) · Circulation Research · doi:10.1161/01.res.0000237662.23539.0b · Cited by 73
(2002) · CRC Press eBooks · doi:10.3109/9780203908877-21 · Cited by 72
Expression of Glia Maturation Factor β mRNA and Protein in Rat Organs and Cells
Zaheer, A., Fink, B. D., & Lim, R. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03237.x · Cited by 71
Self-citationRyu, J.-W., Hong, K. H., Maeng, J. H., Kim, J. B., Ko, J., Park, J. Y., Lee, K., Hong, M., Park, S., Kim, Y. H., et al. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000125705.28058.eb · Cited by 66
Superoxide Anion, Uncoupling Proteins and Alzheimer’s Disease
Wu, Z., Zhao, Y., & Zhao, B. (2010) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.09-104-2 · Cited by 64
Catecholamines in murine bone marrow derived mast cells
Freeman, J. G., Ryan, J. J., Shelburne, C. P., Bailey, D. P., Bouton, L. A., Narasimhachari, N., Domen, J., Siméon, N., Couderc, F., & Stewart, J. K. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00384-8 · Cited by 64
Hormones, Lymphohemopoietic Cytokines and the Neuroimmune Axis
Johnson, R. W., Arkins, S., Dantzer, R., & Kelley, K. W. (1997) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/s0300-9629(96)00277-0 · Cited by 64
Nerve Growth Factor Interactions with Mast Cells
Kritas, S. K., Caraffa, A., Antinolfi, P., Saggini, A., Pantalone, A., Rosati, M., Tei, M. M., Speziali, A., Saggini, R., Pandolfi, F., et al. (2014) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201402700103 · Cited by 63
Impact of stress and mast cells on brain metastases
Theoharides, T. C., Rózniecki, J., Sahagian, G. G., Jocobson, S., Kempuraj, D., Conti, P., & Kalogeromitros, D. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.09.014 · Cited by 62
Self-citationMitochondrial Uncoupling Protein 2 Inhibits Mast Cell Activation and Reduces Histamine Content
Tagen, M., Elorza, Á. A., Kempuraj, D., Boucher, W. S., Kepley, C. L., Shirihai, O. S., & Theoharides, T. C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803422 · Cited by 62
Self-citationComplete amino acid sequence of bovine glia maturation factor beta.
Lim, R., Zaheer, A., & Lane, W. S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5233 · Cited by 61
Self-citationModulation of Neuroinflammation in the Central Nervous System: Role of Chemokines and Sphingolipids
Gualtierotti, R., Guarnaccia, L., Beretta, M., Navone, S. E., Campanella, R., Riboni, L., Rampini, P. M., & Marfia, G. (2017) · Advances in Therapy · doi:10.1007/s12325-016-0474-7 · Cited by 59
Kure, C., Timmer, J. K., & Stough, C. K. K. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00117 · Cited by 58
Johnson, D., Yasui, D. H., & Seeldrayers, P. (1991) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199105000-00005 · Cited by 57
Machado, A., Herrera, A. J., Venero, J. L., Santiago, M., de Pablos, R. M., Villarán, R. F., Espinosa‐Oliva, A. M., Argüelles, S., Soto, M. S., Delgado‐Cortés, M. J., et al. (2011) · Parkinson s Disease · doi:10.4061/2011/393769 · Cited by 56
Mast Cells: Target and Source of Neuropeptides
Töre, F., & Tunçel, N. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789105036 · Cited by 55
Peripheral Immune Signatures in Alzheimer Disease
Goldeck, D., Witkowski, J. M., Fülöp, T., & Pawelec, G. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160222112444 · Cited by 55
Expression of glia maturation factor in neuropathological lesions of Alzheimer's disease
Thangavel, R., Stolmeier, D. A., Yang, X., Anantharam, P., & Zaheer, A. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01232.x · Cited by 54
Self-citationKaimori, J.-Y., Takenaka, M., Nakajima, H., Hamano, T., Horio, M., Sugaya, T., Ito, T., Hori, M., Okubo, K., & Imai, E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301552200 · Cited by 54
Important role of mast cells in multiple sclerosis
Conti, P., & Kempuraj, D. (2015) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2015.11.005 · Cited by 54
Self-citationLi, Y. L., Ye, F., Cheng, X. D., Hu, Y., Zhou, C. Y., Lu, W., & Xie, X. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.04.015 · Cited by 53
Superoxide Anion Regulates the Mitochondrial Free Ca 2+ Through Uncoupling Proteins
Wu, Z., Zhang, J., & Zhao, B. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2427 · Cited by 51
Mori, T., Kabashima, K., Fukamachi, S., Kuroda, E., Sakabe, J., Kobayashi, M., Nakajima, S., Nakano, K., Tanaka, Y., Matsushita, S., et al. (2013) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2013.03.008 · Cited by 51
Peripheral inflammation in neurodegeneration
Träger, U., & Tabrizi, S. J. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1026-0 · Cited by 49
Corticotropin-Releasing Hormone, Microglia and Mental Disorders
Kritas, S. K., Saggini, A., Cerulli, G. G., Caraffa, A., Antinolfi, P., Pantalone, A., Rosati, M., Tei, M. M., Speziali, A., Saggini, R., et al. (2014) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201402700203 · Cited by 49
Hayley, S., Scharf, J., & Anisman, H. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.07.023 · Cited by 48
Amyloid β Peptides Trigger CD47-Dependent Mast Cell Secretory and Phagocytic Responses
Niederhoffer, N., Levy, R., Sick, É., André, P., Coupin, G., Lombard, Y., & Gies, J. (2009) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200902200224 · Cited by 48
Substance P and Alzheimer's Disease: Emerging Novel Roles
Severini, C., Petrella, C., & Calissano, P. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160401114039 · Cited by 48
Neuroinflammation — using big data to inform clinical practice
Dendrou, C. A., McVean, G., & Fugger, L. H. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.171 · Cited by 48
Li, N., Zhang, X., Dong, H., Hu, Y., & Qian, Y. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.01.006 · Cited by 48
Striatal neuropeptide levels in Parkinson's disease patients
Fernandez, A., CEBALLOS, M. L. D., Jenner, P., et al. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90014-x · Cited by 47
Perspectives on mitochondrial uncoupling proteins-mediated neuroprotection
Cardoso, S., Correia, S. C., Carvalho, C., Candeias, E., Plácido, A. I., Duarte, A. I., Seiça, R. M. F., & Moreira, P. I. (2014) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-014-9580-x · Cited by 46
Augmented Expression of Glia Maturation Factor in Alzheimer's Disease
Zaheer, S. A., Thangavel, R., Sahu, S., & Zaheer, A. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.069 · Cited by 44
Self-citationCocchiara, R., Lampiasi, N., Albeggiani, G., Bongiovanni, A., Azzolina, A., & Geraci, D. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00138-1 · Cited by 43
Katsanos, G., Anogeianaki, A., Orso, C. A., Tetè, S., Salini, V., Antinolfi, P., & Sabatino, G. (2008) · PubMed · Cited by 42
Zhao, W., & Schwartz, L. (2004) · CRC Press eBooks · doi:10.1201/b13958-3 · Cited by 42
Thangavel, R., Kempuraj, D., Zaheer, S. A., Raikwar, S. P., Ahmed, M. E., Selvakumar, G. P., Iyer, S. S., & Zaheer, A. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00150 · Cited by 42
Self-citationMast cell inflammasome activity in the meninges regulates EAE disease severity
Russi, A. E., Caulfield, M. E., & Brown, M. A. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.04.009 · Cited by 41
Hayley, S. P., & Anisman, H. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053381611 · Cited by 40
Glia maturation factor-γ mediates neutrophil chemotaxis
Aerbajinai, W., Liu, L., Chin, K., Zhu, J., Parent, C. A., & Rodgers, G. P. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0710424 · Cited by 40
Regulatory roles of mast cells in immune responses
Morita, H., Saito, H., Matsumoto, K., & Nakae, S. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0566-0 · Cited by 40
Induction of microglial apoptosis by corticotropin‐releasing hormone
Ock, J., Lee, H., Kim, S., Lee, W., Choi, D., Park, E. J., Kim, S., Kim, I. K., & Suk, K. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03933.x · Cited by 39
Dysregulated NF-κB Pathway in Peripheral Mononuclear Cells of Alzheimers Disease Patients
Ascolani, A., Balestrieri, E., Minutolo, A., Mosti, S., Spalletta, G., Bramanti, P., Mastino, A., Caltagirone, C., & Macchi, B. (2012) · Current Alzheimer Research · doi:10.2174/156720512799015091 · Cited by 39
Role of TNF in mast cell neuroinflammation and pain.
Gu, Y.-T., Dk, Y., Spinas, E., Kritas, S. K., Saggini, A., Caraffa, A., Antinolfi, P., Saggini, R., & Conti, P. (2015) · PubMed · Cited by 39
The role of Nogo-A in neuroregeneration: A review
Wang, T., Xiong, J.-Q., Ren, X., & Sun, W. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.02.011 · Cited by 38
Kempuraj, D., Thangavel, R., Yang, E., Pattani, S., Zaheer, S. A., Santillan, D. A., Santillan, M. K., & Zaheer, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135776 · Cited by 38
Self-citationPeixoto, P. M. V., Kim, H., Sider, B., Starkov, A. A., Horváth, T. L., & Manfredi, G. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.10.002 · Cited by 37
The emerging neuroprotective role of mitochondrial uncoupling protein-2 in traumatic brain injury
Normoyle, K. P., Kim, M., Farahvar, A., Llano, D., Jackson, K., & Wang, H. (2015) · Translational Neuroscience · doi:10.1515/tnsci-2015-0019 · Cited by 36
Alzheimer's disease and modern lifestyle: what is the role of stress?
Marcello, E. E., Gardoni, F., & Luca, M. D. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13210 · Cited by 36
Role of mast cells in innate and adaptive immunity.
Tetè, S., Tripodi, D., Rosati, M., Conti, F., Maccauro, G., Saggini, A., Salini, V., Cianchetti, E., Caraffa, A., Antinolfi, P., et al. (2012) · PubMed · Cited by 35
Kempuraj, D., Thangavel, R., Fattal, R., Pattani, S., Yang, E., Zaheer, S. A., Santillan, D. A., Santillan, M. K., & Zaheer, A. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1790-z · Cited by 35
Self-citationMast Cell - Glia Dialogue in Chronic Pain and Neuropathic Pain: Blood-Brain Barrier Implications
Skaper, S. D. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666160829105533 · Cited by 35
Interleukin‐1 as a pharmacological target in acute brain injury
Brough, D., Rothwell, N. J., & Allan, S. M. (2015) · Experimental Physiology · doi:10.1113/ep085135 · Cited by 34
Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease
Johansson, P., Almqvist, E. G., Wallin, A., Johansson, J.-O., Andréasson, U., Blennow, K., Zetterberg, H., & Svensson, J. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.10.006 · Cited by 34
Wang, Q., Oyarzabal, E. A., Wilson, B. C., Li, Q., & Hong, J. (2015) · Clinical Science · doi:10.1042/cs20150008 · Cited by 32
Nasal NSAIDs for Alzheimer's Disease
Lehrer, S. P. (2014) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513518658 · Cited by 31
Papadopoulou, N. G., Oleson, L., Kempuraj, D., Donelan, J., Cetrulo, C. L., & Theoharides, T. C. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01833 · Cited by 30
Self-citationCytokines and acute neurodegeneration
Rothwell, N. J. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000223 · Cited by 29
Cytokines as Potential Biomarkers for Parkinson’s Disease: A Multiplex Approach
Litteljohn, D., & Hayley, S. P. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-071-7_7 · Cited by 29
Glia Maturation Factor Expression in Hippocampus of Human Alzheimer’s Disease
Stolmeier, D. A., Thangavel, R., Anantharam, P., Khan, M. M., Kempuraj, D., & Zaheer, A. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1059-3 · Cited by 28
Self-citationHamke, M., Herpfer, I., Lieb, K., Wandelt, C., & Fiebich, B. L. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.026 · Cited by 28
Role of dopamine in the recruitment of immune cells to the nigro-striatal dopaminergic structures
Espinosa‐Oliva, A. M., de Pablos, R. M., Soto, M. S., Villarán, R. F., Carrillo-Jiménez, A., Santiago, M., Venero, J. L., Herrera, A. J., Cano, J., & Machado, A. (2014) · NeuroToxicology · doi:10.1016/j.neuro.2014.01.006 · Cited by 28
Multifaceted roles of neuroinflammation: the need to consider both sides of the coin
Kielian, T. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13530 · Cited by 28
Si, X., Pu, J., & Zhang, B. (2017) · Journal of Movement Disorders · doi:10.14802/jmd.16061 · Cited by 27
Khan, M. M., Kempuraj, D., Zaheer, S. A., & Zaheer, A. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0225-z · Cited by 26
Self-citation
Cited by
The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates
Franceschi, C., Garagnani, P., Morsiani, C., Conte, M., Santoro, A., Grignolio, A., Monti, D., Capri, M., & Salvioli, S. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00061 · Cited by 945
Adamu, A., Li, S., Gao, F., & Xue, G. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1347987 · Cited by 564
An Inflammation-Centric View of Neurological Disease: Beyond the Neuron
Skaper, S. D., Facci, L., Zusso, M., & Giusti, P. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00072 · Cited by 457
Zou, W., Pu, T., Feng, W., Lu, M., Zheng, Y., Du, R., Xiao, M., & Hu, G. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0147-y · Cited by 396
Therapeutic Potential of Centella asiatica and Its Triterpenes: A Review
Sun, B., Wu, L., Wu, Y., Zhang, C., Qin, L., Hayashi, M., Kudo, M., Gao, M., & Liu, T. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.568032 · Cited by 353
Metadata
- Authors
- Kempuraj, D., Thangavel, R., Selvakumar, G. P., Zaheer, S., Ahmed, M. E., Raikwar, S. P., Zahoor, H., Saeed, D., Natteru, P. A., Iyer, S., & Zaheer, A.
- Venue
- Frontiers in Cellular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2017-07-24
- Volume
- 11
- Pages
- 216-216
- ISSN
- 1662-5102 (ISSN-L)
- OpenAlex
- W2738410425
- Cited by
- 365
- References
- 211
- FWCI
- 13.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.